Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: PHARMARON, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-05-19 to 2024-05-18
Current total value of award: $26100
Description: PHARMACOKINETIC STUDY (PK) AT PHARMARON USING A NOVEL POLYMERIC FORMULATION DEVELOPED BY THE UNIVERSITY OF KANSAS ON 1 COMPOUND (NCGC0084604) IN MALE C57BL/6J MICE USING COMPOUND-IN-CHOW DOSING AT 3, 10, AND 30 MG/KG.